Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1000 | 1061 | 1000 | 1201 | 1456 | 1966 |
Fund Return | 0.03% | 6.07% | 0.03% | 6.28% | 7.81% | 7% |
Place in category | 150 | 153 | 150 | 13 | 107 | 92 |
% in Category | 75 | 84 | 75 | 9 | 68 | 77 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
James Alpha Global Real Estate InvI | 248.22M | 8.97 | -3.04 | 5.27 | ||
James Alpha Global Real Estate InvA | 47.04M | -4.11 | -3.71 | 4.27 | ||
Saratoga Large Capitalization Growi | 29.87M | 24.83 | 9.29 | 14.90 | ||
Saratoga Health Biotechnology A | 5M | 5.32 | 3.88 | 6.12 | ||
Saratoga Large Capitalization Growa | 2M | 12.00 | 12.59 | 13.72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 43.27B | 17.24 | 6.89 | 10.05 | ||
Fidelity Select Health Care | 10.35B | 13.63 | 0.73 | 9.96 | ||
T. Rowe Price Health Sciences | 9.53B | 16.59 | 0.90 | 11.27 | ||
Vanguard Health Care Inv | 7.8B | 17.21 | 6.84 | 9.99 | ||
T. Rowe Price Health Sciences I | 6.3B | 16.68 | 1.02 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amgen | US0311621009 | 5.56 | 335.95 | +0.91% | |
Regeneron Pharma | US75886F1075 | 5.13 | 1,150.19 | +1.00% | |
Cencora Inc | US03073E1055 | 4.68 | 226.56 | -0.84% | |
McKesson | US58155Q1031 | 4.68 | 508.16 | -0.68% | |
Cardinal Health | US14149Y1082 | 4.60 | 110.76 | -0.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review